Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
Chahl
L A
LA
Neuropharmacology Laboratory, Faculty of Medicine, University of Newcastle, Australia.
Johnston
P A
PA
D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002552:Cerebral Ventricles / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D006168:Guinea Pigs; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007276:Injections, Intraventricular; D009020:Morphine / Q000633:toxicity*; D009043:Motor Activity / Q000187:drug effects*; D009270:Naloxone / Q000494:pharmacology; D064729:Neurokinin-1 Receptor Antagonists; D013239:Stereotyped Behavior / Q000187:drug effects*; D013373:Substance P / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
D001713:Biphenyl Compounds; D006993:Hypnotics and Sedatives; D064729:Neurokinin-1 Receptor Antagonists; D013373:Substance P; D009270:Naloxone; D009020:Morphine; C066892:CP 96345